West Pharmaceutical Services (WST) Revenue — Quarter Ended Sep 30, 2024
Revenue for the latest quarter decreased modestly relative to the same quarter one year earlier, but increased compared to the immediately preceding quarter. This marks a sequential improvement after a period of decline.
Key takeaway
Quarter ended Sep 30, 2024 · FY2024 Q3
Revenue for the latest quarter decreased modestly relative to the same quarter one year earlier, but increased compared to the immediately preceding quarter. This marks a sequential improvement after a period of decline.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$746.9M
Revenue reported for this quarter.
Quarter-over-quarter
+6.4%
Change from the immediately preceding quarter.
Year-over-year
-0.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$2.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2023 | $732M | +3.3% |
| Mar 31, 2024 | $695.4M | -3.0% |
| Jun 30, 2024 | $702.1M | -6.9% |
| Sep 30, 2024 | $746.9M | -0.1% |
Revenue performance
The company's revenue in the latest quarter was higher than the prior two quarters, though still below the level achieved in the same quarter last year. The sequential increase reflects a reversal of the earlier downward trend.
Quarterly comparison
Compared to the immediately preceding quarter, revenue grew, while compared to the same quarter one year earlier, it contracted slightly. The year-over-year change was minimal, indicating relative stability in top-line performance.
What to watch
Monitor whether the sequential revenue growth can be sustained in the upcoming quarter, given the prior year-over-year decline.